BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
CN Stock MarketDetailed Quotes
688767 Hangzhou Biotest Biotech
- 43.32
- -0.83-1.88%
Market Closed May 15 15:00 CST
4.62BMarket Cap33.32P/E (TTM)
44.48High43.20Low6.59KlotVolume44.16Open44.15Pre Close28.71MTurnover0.62%Turnover Ratio27.26P/E (Static)106.67MShares44.6052wk High1.91P/B4.62BFloat Cap22.8852wk Low52.98Limit Up106.67MShs Float146.02Historical High35.32Limit Down2.90%Amplitude20.95Historical Low1.30Dividend TTM43.57Avg Price3.72KlotAsk3.00%Div YieldTTM100Lot Size2.34KlotBid
Hangzhou Biotest Biotech Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -8.42%130.23M | 54.62%497.65M | 26.03%386.48M | 25.27%267.17M | 34.99%142.21M | -84.67%321.86M | -85.73%306.66M | -88.68%213.28M | -92.00%105.35M | 17.67%2.1B |
| Refunds of taxes and levies | 217.51%4.84M | -48.32%15.56M | -66.75%11.02M | 284.58%8.51M | -37.17%1.52M | -63.35%30.11M | -50.00%33.16M | -95.36%2.21M | -92.30%2.43M | 13.88%82.17M |
| Cash received relating to other operating activities | -53.37%9.5M | -43.08%69.1M | -28.21%46.44M | -8.68%34.65M | 55.28%20.38M | 84.02%121.4M | 42.53%64.69M | 23.57%37.94M | 34.81%13.13M | 139.04%65.97M |
| Cash inflows from operating activities | -11.91%144.57M | 23.01%582.31M | 9.75%443.94M | 22.45%310.34M | 35.74%164.11M | -78.94%473.37M | -82.11%404.51M | -87.08%253.44M | -91.10%120.9M | 19.30%2.25B |
| Goods services cash paid | 0.98%55.32M | 111.73%257.2M | -14.23%174.26M | -25.81%110.07M | -35.21%54.78M | -88.62%121.47M | -81.47%203.17M | -82.73%148.37M | -84.72%84.55M | 61.21%1.07B |
| Staff behalf paid | -4.16%33.4M | -1.24%125.84M | -3.40%88.91M | -14.59%62.68M | -5.57%34.85M | -25.97%127.42M | -18.28%92.03M | -25.04%73.39M | -7.61%36.9M | 40.94%172.11M |
| All taxes paid | 47.55%13.11M | -54.48%15.29M | -2.58%36.7M | -21.67%20.86M | -11.36%8.88M | -85.12%33.6M | -83.08%37.67M | -83.33%26.62M | -78.78%10.02M | 61.20%225.8M |
| Cash paid relating to other operating activities | 67.16%15.18M | -7.32%55.15M | -0.25%35.06M | 0.10%24.1M | -4.32%9.08M | -24.75%59.5M | -16.87%35.14M | 14.23%24.08M | -54.56%9.49M | 53.44%79.07M |
| Cash outflows from operating activities | 8.75%117M | 32.60%453.49M | -8.99%334.92M | -20.10%217.71M | -23.67%107.59M | -77.85%341.99M | -75.03%368.02M | -76.05%272.46M | -78.68%140.96M | 58.26%1.54B |
| Adjustment items of net operating cash flow | ---- | ---- | ---- | ---- | ---- | --0.01 | --0.01 | ---- | ---- | ---- |
| Net cash flows from operating activities | -51.22%27.57M | -1.94%128.83M | 198.76%109.02M | 587.07%92.63M | 381.75%56.52M | -81.32%131.38M | -95.37%36.49M | -102.31%-19.02M | -102.88%-20.06M | -22.56%703.21M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 21,861.25%2.2B | 4,795.63%6.39B | 2,893.36%3.61B | 1,079.70%1.19B | --10M | -76.30%130.56M | -56.96%120.5M | -49.75%100.5M | ---- | --550.84M |
| Cash received from returns on investments | 17,222.54%2.63M | 122.49%8.54M | 49.68%5.61M | -55.73%1.49M | -95.83%15.21K | -74.04%3.84M | -60.03%3.74M | -37.62%3.36M | --364.93K | 6,409.25%14.79M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | -55.84%80.59K | ---- | ---- | ---- | --182.49K | ---- | ---- | ---- | --0 |
| Cash inflows from investing activities | 21,854.21%2.2B | 4,655.74%6.4B | 2,807.65%3.61B | 1,043.02%1.19B | 2,644.41%10.02M | -76.21%134.59M | -57.06%124.24M | -49.43%103.86M | --364.93K | 248,845.28%565.63M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -94.07%9.97M | 334.31%245.05M | 1,628.84%232.27M | 1,457.54%181.84M | 1,736.64%168.18M | -68.46%56.42M | -91.22%13.44M | -91.59%11.67M | -74.79%9.16M | -10.63%178.92M |
| Cash paid to acquire investments | --1.64B | 183,946.70%6.99B | 95,824.47%3.65B | 255,020.00%1.28B | ---- | -98.69%3.8M | -98.69%3.8M | -99.83%500K | --500K | -27.50%290M |
| Cash outflows from investing activities | 880.54%1.65B | 11,919.84%7.24B | 22,413.59%3.88B | 11,870.83%1.46B | 1,641.55%168.18M | -87.16%60.22M | -96.11%17.24M | -97.16%12.17M | -73.42%9.66M | -21.87%468.92M |
| Net cash flows from investing activities | 447.52%549.67M | -1,227.25%-838.25M | -350.91%-268.49M | -394.89%-270.36M | -1,602.16%-158.17M | -23.11%74.36M | 169.62%107.01M | 141.05%91.68M | 74.42%-9.29M | 116.12%96.71M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | --4.17M | --4.18M | --4.18M | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | --4.18M | --4.18M | ---- | ---- |
| Cash from borrowing | ---- | ---- | ---- | ---- | ---- | --239.74K | --202.84K | --202.84K | ---- | ---- |
| Cash received relating to other financing activities | ---- | --24.87M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | ---- | 463.65%24.87M | ---- | ---- | ---- | --4.41M | --4.38M | --4.38M | ---- | ---- |
| Borrowing repayment | ---- | --148.25K | -22.12%289.74K | --66.33K | ---- | ---- | -93.03%372.05K | ---- | ---- | -51.95%5.29M |
| Dividend interest payment | --53.21M | -64.36%83.65M | -65.08%81.94M | -63.74%81.94M | ---- | -26.67%234.67M | -26.67%234.67M | -26.46%225.97M | ---- | 1,430.29%320.01M |
| Cash payments relating to other financing activities | ---- | 141.01%45.63M | 639.13%44.97M | 6,277.34%86.36M | 6,061.63%40.68M | 157.35%18.93M | -63.32%6.08M | -49.02%1.35M | --660.16K | -55.56%7.36M |
| Cash outflows from financing activities | 30.81%53.21M | -48.97%129.42M | -47.25%127.2M | -25.94%168.36M | 6,061.63%40.68M | -23.76%253.6M | -29.48%241.12M | -27.92%227.32M | -86.83%660.16K | 586.35%332.65M |
| Net cash flows from financing activities | -30.81%-53.21M | 58.04%-104.55M | 46.27%-127.2M | 24.48%-168.36M | -6,061.63%-40.68M | 25.09%-249.19M | 30.76%-236.74M | 29.31%-222.94M | 86.83%-660.16K | -140.90%-332.65M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -154.13%-429.7K | -3.62%10.5M | -156.03%-10.69M | -81.65%4.24M | 105.47%793.77K | -89.62%10.89M | -84.42%19.08M | -63.76%23.08M | -190.30%-14.5M | 807.69%104.91M |
| Net increase in cash and cash equivalents | 469.97%523.6M | -2,368.44%-803.48M | -300.96%-297.36M | -168.75%-341.85M | -217.93%-141.53M | -105.69%-32.55M | -117.90%-74.16M | -136.42%-127.2M | -106.85%-44.52M | -48.29%572.18M |
| Add:Begin period cash and cash equivalents | -42.13%1.1B | -1.68%1.91B | -1.68%1.91B | -1.68%1.91B | -1.69%1.91B | 41.84%1.94B | 37.51%1.94B | 41.84%1.94B | 41.85%1.94B | 423.90%1.37B |
| End period cash equivalent | -7.84%1.63B | -42.13%1.1B | -13.71%1.61B | -13.64%1.57B | -6.85%1.77B | -1.68%1.91B | 2.23%1.87B | 5.57%1.81B | -6.06%1.9B | 41.84%1.94B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.